Exhibit 1
Joint Filing Agreement
The undersigned hereby agree to make joint filings of Form 13D with the
U.S. Securities and Exchange Commission with respect to their beneficial
ownership of the common stock, par value $0.01 per share, of Elite
Pharmaceuticals, Inc., a Delaware corporation, including all amendments thereto.
Date: December 16, 2002
/s/ Xxxx X. Xxxxx
-----------------------------
XXXX X. XXXXX
/s/ Xxxxxx Xxxxx
-----------------------------
XXXXXX XXXXX
XXXXX XXXXX CORP.
By: /s/ Xxxx X. Xxxxx
-------------------------------
Name: Xxxx X. Xxxxx
Title: Chief Executive Officer
